Oloya, Mario .

HRN: 00-07-13  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/16/2025
CLINDAMYCIN 150MG/ML, 4ML (AMP)
05/16/2025
05/23/2025
IV
600MG
Q8
CELLULITIS
Waiting Final Action 
05/16/2025
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
05/16/2025
05/23/2025
IV
1.5gm
Q6h
Cellulitis
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: